Investigating the population health impact of an oral tobacco–derived nicotine pouch product utilizing a three-product tobacco use population model

These findings suggest that regulatory authorization of <i>on!</i> ^® nicotine pouches could yield a net public health benefit by lowering all-cause mortality and reducing the prevalence of use of tobacco products associated with greater health risks.